Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments? von Bewersdorf, Jan Philipp, Zeidan, Amer M

Volltext

Venetoclax as monotherapy and in combination with hypomethylating agents or low dose cytarabine in relapsed and treatment refractory acute myeloid leukemia: a systematic review and... von Bewersdorf, Jan Philipp, Giri, Smith, Wang, Rong, Williams, Robert T, Tallman, Martin S, Zeidan, Amer M, Stahl, Maximilian

Volltext

Use of immunosuppressive therapy for management of myelodysplastic syndromes: a systematic review and meta-analysis von Stahl, Maximilian, Bewersdorf, Jan Philipp, Giri, Smith, Wang, Rong, Zeidan, Amer M

Volltext

BiTEs, DARTS, BiKEs and TriKEs-Are Antibody Based Therapies Changing the Future Treatment of AML? von Allen, Cecily, Zeidan, Amer M, Bewersdorf, Jan Philipp

Volltext

Emerging treatment options for patients with high-risk myelodysplastic syndrome von Bewersdorf, Jan Philipp, Carraway, Hetty, Prebet, Thomas

Volltext

Epigenetic therapy combinations in acute myeloid leukemia: what are the options? von Bewersdorf, Jan Philipp, Shallis, Rory, Stahl, Maximilian, Zeidan, Amer M.

Volltext

Pericytes are protective in experimental pneumococcal meningitis through regulating leukocyte infiltration and blood-brain barrier function von Teske, Nina C, Dyckhoff-Shen, Susanne, Beckenbauer, Paul, Bewersdorf, Jan Philipp, Engelen-Lee, Joo-Yeon, Hammerschmidt, Sven, Kälin, Roland E, Pfister, Hans-Walter, Brouwer, Matthijs C, Klein, Matthias, Glass, Rainer, van de Beek, Diederik, Koedel, Uwe

Volltext

Early and aggressive ISR with a polymer- and carrier-free drug-coated stent system von Loch, Alexander, Bewersdorf, Jan Philipp, Veeriah, Ramesh Singh

Volltext

Hypomethylating Agents and FLT3 Inhibitors As Maintenance Treatment for Acute Myeloid Leukemia and Myelodysplastic Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation... von Bewersdorf, Jan Philipp, Allen, Cecily, Mirza, Abu-Sayeef, Grimshaw, Alyssa A., Giri, Smith, Podoltsev, Nikolai A., Gowda, Lohith, Cho, Christina, Tallman, Martin S., Zeidan, Amer M., Stahl, Maximilian

Volltext

Global Disparities in the Characteristics and Outcomes of Leukemia Clinical Trials: A Cross-Sectional Study of the ClinicalTrials.gov Database von Alhajahjeh, Abdulrahman, Rotter, Lara K, Stempel, Jessica M, Grimshaw, Alyssa A, Bewersdorf, Jan Philipp, Blaha, Ondrej, Kewan, Tariq, Podoltsev, Nikolai A, Shallis, Rory M, Mendez, Lourdes, Stahl, Maximilian, Zeidan, Amer M

Volltext

Translating recent advances in the pathogenesis of acute myeloid leukemia to the clinic von Bewersdorf, Jan Philipp, Abdel-Wahab, Omar

Volltext

Generic atorvastatin is as effective as the brand-name drug (LIPITOR ® ) in lowering cholesterol levels: a cross-sectional retrospective cohort study von Loch, Alexander, Bewersdorf, Jan Philipp, Kofink, Daniel, Ismail, Dzafir, Abidin, Imran Zainal, Veriah, Ramesh Singh

Volltext

The Current Understanding of and Treatment Paradigm for Newly-Diagnosed TP53-Mutated Acute Myeloid Leukemia von Shallis, Rory M., Stahl, Maximilian, Bewersdorf, Jan Philipp, Zeidan, Amer M.

Volltext

Mast Cells Are Activated by Streptococcus pneumoniae In Vitro but Dispensable for the Host Defense Against Pneumococcal Central Nervous System Infection In Vivo von Fritscher, Johanna, Amberger, Daniel, Dyckhoff, Susanne, Bewersdorf, Jan Philipp, Masouris, Ilias, Voelk, Stefanie, Hammerschmidt, Sven, Schmetzer, Helga Maria, Klein, Matthias, Pfister, Hans-Walter, Koedel, Uwe

Volltext

Toward a more patient‐centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the Internatio... von Efficace, Fabio, Buckstein, Rena, Abel, Gregory A., Giesinger, Johannes M., Fenaux, Pierre, Bewersdorf, Jan Philipp, Brunner, Andrew M., Bejar, Rafael, Borate, Uma, DeZern, Amy E., Greenberg, Peter, Roboz, Gail J., Savona, Michael R., Sparano, Francesco, Boultwood, Jacqueline, Komrokji, Rami, Sallman, David A., Xie, Zhuoer, Sanz, Guillermo, Carraway, Hetty E., Taylor, Justin, Nimer, Stephen D., Della Porta, Matteo Giovanni, Santini, Valeria, Stahl, Maximilian, Platzbecker, Uwe, Sekeres, Mikkael A., Zeidan, Amer M.

Volltext

Transforming growth factor (TGF)-β pathway as a therapeutic target in lower risk myelodysplastic syndromes von Bewersdorf, Jan Philipp, Zeidan, Amer M.

Volltext

Immunotherapy in acute myeloid leukemia and myelodysplastic syndromes: The dawn of a new era? von Liu, Yuxin, Bewersdorf, Jan Philipp, Stahl, Maximilian, Zeidan, Amer M.

Volltext

A review of FLT3 inhibitors in acute myeloid leukemia von Zhao, Jennifer C., Agarwal, Sonal, Ahmad, Hiba, Amin, Kejal, Bewersdorf, Jan Philipp, Zeidan, Amer M.

Volltext

Leukapheresis for the management of hyperleukocytosis in acute myeloid leukemia—A systematic review and meta‐analysis von Bewersdorf, Jan P., Giri, Smith, Tallman, Martin S., Zeidan, Amer M., Stahl, Maximilian

Volltext

Moving toward disease modification in polycythemia vera von Bewersdorf, Jan Philipp, How, Joan, Masarova, Lucia, Bose, Prithviraj, Pemmaraju, Naveen, Mascarenhas, John, Rampal, Raajit K

Volltext